Literature DB >> 30355495

Intrinsic Nucleotide Preference of Diversifying Base Editors Guides Antibody Ex Vivo Affinity Maturation.

Liu Daisy Liu1, Min Huang1, Pengfei Dai1, Tingting Liu1, Shuangshuang Fan1, Xueqian Cheng2, Yaofeng Zhao2, Leng-Siew Yeap3, Fei-Long Meng4.   

Abstract

Base editors (BEs) are emerging tools used for precision correction or diversifying mutation. It provides a potential way to recreate somatic hypermutations (SHM) for generating high-affinity antibody, which is usually screened from antigen-challenged animal models or synthetic combinatorial libraries. By comparing somatic mutations in the same genomic context, we screened engineered deaminases and CRISPR-deaminase coupling approaches and updated diversifying base editors (DBEs) to generate SHM. The deaminase used in DBEs retains its intrinsic nucleotide preference and mutates cytidines at its preferred motifs. DBE with AID targets the same hotspots as physiological AID does in vivo, while DBE with other deaminases generates distinct mutation profiles from the same DNA substrate. Downstream DNA repair pathways further diversified the sequence, while Cas9-nickase restricted mutation spreading. Finally, application of DBE in an antibody display system achieved antibody affinity maturation ex vivo. Our findings provide insight of DBE working mechanism and an alternative antibody engineering approach.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AID; APOBEC; CRISPR; SHM; antibody affinity maturation; antibody diversification; base editor; deaminase; diversifying base editor; somatic hypermutation

Mesh:

Substances:

Year:  2018        PMID: 30355495     DOI: 10.1016/j.celrep.2018.09.090

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  10 in total

1.  Development and Characterization of a Modular CRISPR and RNA Aptamer Mediated Base Editing System.

Authors:  Juan Carlos Collantes; Victor M Tan; Huiting Xu; Melany Ruiz-Urigüen; Amer Alasadi; Jingjing Guo; Hanlin Tao; Chi Su; Katarzyna M Tyc; Tommaso Selmi; John J Lambourne; Jennifer A Harbottle; Jesse Stombaugh; Jinchuan Xing; Ceri M Wiggins; Shengkan Jin
Journal:  CRISPR J       Date:  2021-02

Review 2.  Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.

Authors:  Andrew V Anzalone; Luke W Koblan; David R Liu
Journal:  Nat Biotechnol       Date:  2020-06-22       Impact factor: 54.908

3.  Controllable genome editing with split-engineered base editors.

Authors:  Kiara N Berríos; Niklaus H Evitt; Rachel A DeWeerd; Diqiu Ren; Meiqi Luo; Aleksia Barka; Tong Wang; Caroline R Bartman; Yemin Lan; Abby M Green; Junwei Shi; Rahul M Kohli
Journal:  Nat Chem Biol       Date:  2021-10-18       Impact factor: 15.040

4.  C-terminal deletion-induced condensation sequesters AID from IgH targets in immunodeficiency.

Authors:  Xia Xie; Tingting Gan; Bing Rao; Weiwei Zhang; Rohit A Panchakshari; Dingpeng Yang; Xiong Ji; Yu Cao; Frederick W Alt; Fei-Long Meng; Jiazhi Hu
Journal:  EMBO J       Date:  2022-04-26       Impact factor: 14.012

5.  Determinants of Base Editing Outcomes from Target Library Analysis and Machine Learning.

Authors:  Mandana Arbab; Max W Shen; Beverly Mok; Christopher Wilson; Żaneta Matuszek; Christopher A Cassa; David R Liu
Journal:  Cell       Date:  2020-06-12       Impact factor: 41.582

6.  Precision genome editing using cytosine and adenine base editors in mammalian cells.

Authors:  Tony P Huang; Gregory A Newby; David R Liu
Journal:  Nat Protoc       Date:  2021-01-18       Impact factor: 13.491

7.  Ex vivo evolution of human antibodies by CRISPR-X: from a naive B cell repertoire to affinity matured antibodies.

Authors:  Marie-Claire Devilder; Melinda Moyon; Laetitia Gautreau-Rolland; Benjamin Navet; Jeanne Perroteau; Florent Delbos; Marie-Claude Gesnel; Richard Breathnach; Xavier Saulquin
Journal:  BMC Biotechnol       Date:  2019-02-18       Impact factor: 2.563

Review 8.  Full-Spectrum Targeted Mutagenesis in Plant and Animal Cells.

Authors:  Brian Iaffaldano; Jakob Reiser
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923

9.  Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibody.

Authors:  Tingting Li; Hongmin Cai; Yapei Zhao; Yanfang Li; Yanling Lai; Hebang Yao; Liu Daisy Liu; Zhou Sun; Martje Fentener van Vlissingen; Thijs Kuiken; Corine H GeurtsvanKessel; Ning Zhang; Bingjie Zhou; Lu Lu; Yuhuan Gong; Wenming Qin; Moumita Mondal; Bowen Duan; Shiqi Xu; Audrey S Richard; Hervé Raoul; JianFeng Chen; Chenqi Xu; Ligang Wu; Haisheng Zhou; Zhong Huang; Xuechao Zhang; Jun Li; Yanyan Wang; Yuhai Bi; Barry Rockx; Junfang Chen; Fei-Long Meng; Dimitri Lavillette; Dianfan Li
Journal:  EMBO Mol Med       Date:  2021-11-17       Impact factor: 12.137

10.  Gene editing and CRISPR in the clinic: current and future perspectives.

Authors:  Matthew P Hirakawa; Raga Krishnakumar; Jerilyn A Timlin; James P Carney; Kimberly S Butler
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.